← FDA Drug Approvals (Drugs@FDA)

OXLUMO

NDA · New Drug Application · Sponsor: ALNYLAM PHARMS INC · Approved 2020-11-23

Drug application

FDA Application #

NDA214103

Application type

New Drug Application

Brand name

OXLUMO

Generic name

LUMASIRAN

Active ingredients

LUMASIRAN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ALNYLAM PHARMS INC

Manufacturer

Alnylam Pharmaceuticals, Inc.

First approval

2020-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown